JPS6479186A - Ester substituted thienotriazolodiazepine compound and medicinal use thereof - Google Patents

Ester substituted thienotriazolodiazepine compound and medicinal use thereof

Info

Publication number
JPS6479186A
JPS6479186A JP63140146A JP14014688A JPS6479186A JP S6479186 A JPS6479186 A JP S6479186A JP 63140146 A JP63140146 A JP 63140146A JP 14014688 A JP14014688 A JP 14014688A JP S6479186 A JPS6479186 A JP S6479186A
Authority
JP
Japan
Prior art keywords
substituted
alkyl
formula
expressed
action
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP63140146A
Other languages
English (en)
Other versions
JPH0555511B2 (ja
Inventor
Tetsuya Tawara
Minoru Moriwaki
Yukio Abe
Michio Terasawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Welfide Corp
Original Assignee
Welfide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Welfide Corp filed Critical Welfide Corp
Priority to JP63140146A priority Critical patent/JPS6479186A/ja
Publication of JPS6479186A publication Critical patent/JPS6479186A/ja
Publication of JPH0555511B2 publication Critical patent/JPH0555511B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP63140146A 1987-06-08 1988-06-07 Ester substituted thienotriazolodiazepine compound and medicinal use thereof Granted JPS6479186A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP63140146A JPS6479186A (en) 1987-06-08 1988-06-07 Ester substituted thienotriazolodiazepine compound and medicinal use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14284187 1987-06-08
JP63140146A JPS6479186A (en) 1987-06-08 1988-06-07 Ester substituted thienotriazolodiazepine compound and medicinal use thereof

Publications (2)

Publication Number Publication Date
JPS6479186A true JPS6479186A (en) 1989-03-24
JPH0555511B2 JPH0555511B2 (ja) 1993-08-17

Family

ID=15324858

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63140146A Granted JPS6479186A (en) 1987-06-08 1988-06-07 Ester substituted thienotriazolodiazepine compound and medicinal use thereof

Country Status (4)

Country Link
US (1) US5028603A (ja)
EP (1) EP0316456A4 (ja)
JP (1) JPS6479186A (ja)
WO (1) WO1988009792A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30676A (en) * 1986-07-22 1997-09-16 Boehringer Ingelhein Kg Hetrazepine compounds which have useful pharmaceutical utility
US5480881A (en) * 1990-06-01 1996-01-02 Korth; Ruth Treatment of disease with paf-acether antagonists and procedure determining their efficacy
CA1324863C (en) * 1988-01-30 1993-11-30 Minoru Moriwaki Thienotriazolodiazepine compounds and pharmaceutical uses thereof
AT394562B (de) * 1989-03-31 1992-05-11 Scras Verfahren zur herstellung neuer thieno-triazolodiazepine
GB8907256D0 (en) * 1989-03-31 1989-05-17 Rech Et D Applic Scient Scras New derivatives of hetrazepine as anti-asthmatic anti-allergic and gastro-intestinal protectors
GB8907257D0 (en) * 1989-03-31 1989-05-17 Rech Et D Applic Scient Scras New derivatives of hetrazepine as anti-paf and anti-ischemic agents
GB8911030D0 (en) * 1989-05-13 1989-06-28 Scras Hetrazepine derivatives
DE4010528A1 (de) * 1990-04-02 1991-10-17 Boehringer Ingelheim Kg Praeparativ chromatographisches trennverfahren zur herstellung enantiomerenreiner hetrazepine
AT394563B (de) * 1990-05-09 1992-05-11 Scras Verfahren zur herstellung von thieno-triazolodiazepinderivaten

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3435973A1 (de) * 1984-10-01 1986-04-10 Boehringer Ingelheim KG, 6507 Ingelheim Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
ES2037013T3 (es) * 1986-01-21 1993-06-16 Boehringer Ingelheim Kg Procedimiento para preparar tieno-1,4-diazepinas.
JPH06187623A (ja) * 1992-12-15 1994-07-08 Matsushita Electric Ind Co Ltd 磁気記録再生装置
JPH06222718A (ja) * 1993-01-27 1994-08-12 Sekisui Chem Co Ltd 装飾用粘着シートの貼り付け方法

Also Published As

Publication number Publication date
JPH0555511B2 (ja) 1993-08-17
EP0316456A1 (en) 1989-05-24
EP0316456A4 (en) 1990-05-14
WO1988009792A1 (en) 1988-12-15
US5028603A (en) 1991-07-02

Similar Documents

Publication Publication Date Title
AU4257889A (en) Sulphonamido-phenylalkanoic acid derivatives having thromboxane A2 antagonist activity
EP0395328A3 (en) Penylpyrimidone derivates and their use as therapeutic agents
MX9203744A (es) Analogos de camptotecina solubles en agua utiles para inhibir el crecimiento de celulas de tumor de animal.
ATE150462T1 (de) Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung
IL85988A (en) 1-phenyl-3-naphthalenyloxy-propanamines,process for their preparation and pharmaceutical compositions containing them
NO167979C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazopyridiner
ATE146473T1 (de) Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung
JPS6479186A (en) Ester substituted thienotriazolodiazepine compound and medicinal use thereof
ES8207180A1 (es) Procedimiento de fabricacion de derivados de tetrahidro-5,67,7a 4h-tieno (3,2-c) piridinona-2 .
IE820539L (en) Substituted biphenyl compounds
AU1488392A (en) Pharmeceutical composition for the treatment of autoimmune diseases
EP0387070A3 (en) N-containing heterocyclic compounds, processes for the preparation thereof and composition comprising the same
JPS57140754A (en) Dihydroxybenzoic acid derivative and physiologically active preparation containing the same
ATE38982T1 (de) Guanidinmethylcyclohexancarbonsaeure-derivate, verfahren zur herstellung und pharmazeutische mittel.
ES8307224A1 (es) Un metodo para preparar derivados de pirazolina.
ATE9584T1 (de) Antibakterielle beta-lactam-verbindungen, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
IE781467L (en) 4"-ureido-oleandomycin derivatives
CA2128202A1 (en) Alkyl Derivatives of Trazodone with CNS Activity
ES8205804A1 (es) Un procedimiento para la preparacio,n de nuevos derivados de denzopirano 2,3-d-v-triazol.
DE3675277D1 (de) Catechinamide, verfahren zu ihrer herstellung, zwischenprodukte und pharmazeutische zubereitung.
RU95107154A (ru) Производные 5,6-дигидро-4н-тиено[3,4-c]пиррола, их получение и содержащие их медикамент и фармацевтическая композиция
EP0318166A3 (en) Isoxazolo[4,5-c]azepine derivatives, process for their preparation and pharmaceutical compositions containing them
IT1205114B (it) 2-selenometil-1,4-diidropiridine,procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
IL90172A (en) 2,3-dihydro-5-(substituted phenyl)-imidazo(1,2-a)furo and thieno pyridine derivatives,their preparation and pharmaceutical compositions containing them
IT8948511A0 (it) Nuovi sali dell'acido nicotinico con composti aminobenzilici e loro impiego farmaceutico.